Protein discovery offers hope for prostate cancer
21 January, 2008
Australian scientists are researching a possible way of making aggressive prostate cancer cells less invasive after their discovery of a protein essential for the normal functioning of cells.
Researchers create metal memory foam
27 December, 2007
In the world of commercial materials, lighter and cheaper is usually better — especially when those attributes are coupled with superior strength and special properties, such as a recently developed material's ability to remember its original shape after it has been deformed by a physical or magnetic force.
Developing therapy-resistant cancers for research
17 December, 2007
A cancer cell line that is resistant to one of the newest classes of cancer treatments has been developed by researchers who already are using it to determine treatment alternatives for when it starts appearing in patients.
Violent sex acts boost insect's immune system
10 December, 2007
Scientists have discovered that many insects have a form of immune memory similar to the vertebrate system, which protects them against reinvasion by previously encountered pathogens.
Could lithium medicine prolong your life?
06 December, 2007 by Keiran Jones, Journalist
The common mood-affecting drug, lithium, could double as an anti-ageing medication, according to a recent study in the online version of the Journal of Biological Chemistry
Growing human embryonic stem cells
06 December, 2007 | Supplied by: Life Technologies
Human embryonic stem cells (hESCs), the building blocks for all cell types in the human body, may be harnessed for potential applications in cell therapy and regenerative medicine. Currently, hESC culture and expansion methods require the use of serum, mouse or human fibroblast feeder layers, or feeder-conditioned medium. These culture methods are labour intensive and hard to scale, and it is difficult to maintain hESCs in an undifferentiated state because of significant sources of variability such as growth factor fluctuations during culture.
Research links stress to ADHD
05 December, 2007
Researchers from the University of Melbourne and the Howard Florey Institute have discovered a biological cause for why children with ADHD are not able to handle stressful environments.
Research collaboration for green manufacturing systems
04 December, 2007
A research alliance has recently been announced between the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) and The Dow Chemical Company.
A fresh FACE for climate research
03 December, 2007
Scientists will have access to the latest in climate change technology to investigate future atmospheric conditions and their impact on plant crops, after the official opening in November of a $3.7 million climate change research facility in Horsham, Victoria.
Advances in early stage ovarian cancer diagnosis
30 November, 2007
HealthLinx has reached an agreement with The University of Liverpool (UK) to in-license patented biomarkers and antibodies that show efficacy in detecting grade one and two ovarian cancer.
Alzheimer's vaccine gets European patent
29 November, 2007
The Vienna-based company, Affiris, announced that it has been granted a Europe-wide patent for a pool of peptide sequences that are key elements of its Alzheimer’s vaccine. The company will be able to use these newly patented components to manufacture an optimised vaccine against beta-amyloid, the peptide responsible for the onset of Alzheimer’s disease.
Childhood leukaemia researcher wins award
26 November, 2007
Petra Bachmann was announced this year’s Open Senior Division winner in the highly respected Coast Association Tow Research Awards.
EMBO elects three top Australian scientists
26 November, 2007
Three Australian scientists have been elected as members of the European Molecular Biology Organization (EMBO), one of the world’s most respected scientific organisations.
A guide to inhibit measles infection
26 November, 2007
Infecting almost 20 million people worldwide each year, the measles virus remains a dangerous, highly contagious disease despite extensive vaccination efforts. However, recent advancements in understanding the pathogen’s binding mechanism could provide a new strategy to fight infection.
Cancer-causing protein pathway identified
19 November, 2007
Researchers have discovered a protein pathway that causes two common forms of cancer, neuroblastoma (the most common tumour of infants) and breast cancer.
